Skip to main content
Erschienen in: Current Psychiatry Reports 7/2016

01.07.2016 | Psychiatry in Primary Care (BN Gaynes, Section Editor)

Psychiatric and Medical Comorbidity in the Primary Care Geriatric Patient—An Update

Erschienen in: Current Psychiatry Reports | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

The mental health needs of older primary care patients are now widely recognized if not widely addressed. The range of behavioral health approaches including co-locating psychiatrists and integrating mental health professionals as care managers into primary care sites is extensive and growing. Nonetheless the primary care provider remains the first line of defense against mental disorders, most commonly depression and anxiety that accompany and exacerbate common physical conditions. The excess, potentially avoidable disability that results from comorbidity makes it imperative that early recognition and evidence based intervention occur. Multi-morbidity and polypharmacy make intervention a challenge. Psychotherapy can help overcome comorbidity depression however the most accessible intervention would be an antidepressant FDA approved for both anxiety and depressive disorders. For all these reasons, a focus on physical conditions most commonly associated with mental disorders can foster early recognition before the older patient’s care becomes overwhelmingly complicated.
Literatur
1.
Zurück zum Zitat Gallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML. Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry. 2005;13(9):748–55.CrossRefPubMedPubMedCentral Gallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML. Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry. 2005;13(9):748–55.CrossRefPubMedPubMedCentral
2.••
Zurück zum Zitat Gallo JJ, Hwang S, Joo JH, Bogner HR, Morales KH, Bruce ML, et al. Multimorbidity, depression, and mortality in primary care: randomized clinical trial of an evidence-based depression care management program on mortality risk. J Gen Intern Med. 2015. doi:10.1007/s11606-015-3524-y. Data from large a, multi-site, primary care intervention trial demonstrated that a depression care management program countered the amplifying effect of increasing morbidity on mortality. All patients exhibited increasing rates of death as their rates of morbidity increased. Depressed patients in the usual care arm experienced substantially greater death rates than all others. Gallo JJ, Hwang S, Joo JH, Bogner HR, Morales KH, Bruce ML, et al. Multimorbidity, depression, and mortality in primary care: randomized clinical trial of an evidence-based depression care management program on mortality risk. J Gen Intern Med. 2015. doi:10.​1007/​s11606-015-3524-y. Data from large a, multi-site, primary care intervention trial demonstrated that a depression care management program countered the amplifying effect of increasing morbidity on mortality. All patients exhibited increasing rates of death as their rates of morbidity increased. Depressed patients in the usual care arm experienced substantially greater death rates than all others.
3.•
Zurück zum Zitat Avari JN, Alexopoulos GS. Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke. Am J Geriatr Psychiatry. 2015;23(5):477–87. The authors describe in detail the elements of psychotherapeutic interventions for depression specific to physical illnesses which may be acute or chronic. The approach is comprehensive yet pragmatic, representing anew that he psychosocial and biomedical determinants of health and well being cannot be separated. Avari JN, Alexopoulos GS. Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke. Am J Geriatr Psychiatry. 2015;23(5):477–87. The authors describe in detail the elements of psychotherapeutic interventions for depression specific to physical illnesses which may be acute or chronic. The approach is comprehensive yet pragmatic, representing anew that he psychosocial and biomedical determinants of health and well being cannot be separated.
5.
Zurück zum Zitat Albrecht JS, Huang TY, Park Y, Langenberg P, Harris I, Netzer G, et al. New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2015. doi:10.1002/gps.4348.PubMed Albrecht JS, Huang TY, Park Y, Langenberg P, Harris I, Netzer G, et al. New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2015. doi:10.​1002/​gps.​4348.PubMed
6.
Zurück zum Zitat Liao WC, Lin CL, Chang SN, Tu CY, Kao CH. The association between chronic obstructive pulmonary disease and dementia: a population-based retrospective cohort study. Eur J Neurol. 2015;22(2):334–40. doi:10.1111/ene.12573.CrossRefPubMed Liao WC, Lin CL, Chang SN, Tu CY, Kao CH. The association between chronic obstructive pulmonary disease and dementia: a population-based retrospective cohort study. Eur J Neurol. 2015;22(2):334–40. doi:10.​1111/​ene.​12573.CrossRefPubMed
8.
Zurück zum Zitat Salte K, Titlestad I, Halling A. Depression is associated with poor prognosis in patients with chronic obstructive pulmonary disease—a systematic review. Dan Med J. 2015;62(10):A5137.PubMed Salte K, Titlestad I, Halling A. Depression is associated with poor prognosis in patients with chronic obstructive pulmonary disease—a systematic review. Dan Med J. 2015;62(10):A5137.PubMed
9.
Zurück zum Zitat Alexopoulos GS, Kiosses DN, Sirey JA, et al. Personalized intervention for people with depression and severe COPD. Br J Psychiatry. 2013;202:235–6.CrossRefPubMedPubMedCentral Alexopoulos GS, Kiosses DN, Sirey JA, et al. Personalized intervention for people with depression and severe COPD. Br J Psychiatry. 2013;202:235–6.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Schüz N, Walters JA, Cameron-Tucker H, Scott J, Wood-Baker R, Walters EH. Patient anxiety and depression moderate the effects of increased self-management knowledge on physical activity: a secondary analysis of a randomised controlled trial on health-mentoring in COPD. COPD. 2015;12(5):502–9. doi:10.3109/15412555.2014.995289.CrossRefPubMed Schüz N, Walters JA, Cameron-Tucker H, Scott J, Wood-Baker R, Walters EH. Patient anxiety and depression moderate the effects of increased self-management knowledge on physical activity: a secondary analysis of a randomised controlled trial on health-mentoring in COPD. COPD. 2015;12(5):502–9. doi:10.​3109/​15412555.​2014.​995289.CrossRefPubMed
11.
Zurück zum Zitat Borson S, Claypoole K, McDonald GJ. Depression and chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry. 1998;2:115–30. Borson S, Claypoole K, McDonald GJ. Depression and chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry. 1998;2:115–30.
12.
Zurück zum Zitat Kennedy GJ. Pharmacotherapy, in geriatric depression: a clinical guide. New York: The Guilford Press; 2015. p. 34–63. Kennedy GJ. Pharmacotherapy, in geriatric depression: a clinical guide. New York: The Guilford Press; 2015. p. 34–63.
13.
Zurück zum Zitat Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the heart and soul study. JAMA. 2003;290:215–21.CrossRefPubMedPubMedCentral Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the heart and soul study. JAMA. 2003;290:215–21.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66(6):814–22.CrossRefPubMed van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66(6):814–22.CrossRefPubMed
15.
Zurück zum Zitat Lloyd CE, Roy T, Nouwen A, Chauhan AM. Epidemiology of depression in diabetes: international and cross-cultural issues. J Affect Disord. 2012;142(Suppl):S22–9.CrossRefPubMed Lloyd CE, Roy T, Nouwen A, Chauhan AM. Epidemiology of depression in diabetes: international and cross-cultural issues. J Affect Disord. 2012;142(Suppl):S22–9.CrossRefPubMed
16.••
Zurück zum Zitat Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry. 2006;63(3):283–8. doi:10.1001/archpsyc.63.3.283. This is a landmark study of pharmacologic intervention for depression following hospitalization for an acute coronary event. Prior episodes of depression and currently elevated level of severity predicted which patients would benefit for sertraline. Some have argued that patients hospitalized for an acute coronary event who have a prior history of major depression should receive prophylactic antidepressant treatment even is their level of symptoms do not reach criteria for a major depressive disorder. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry. 2006;63(3):283–8. doi:10.​1001/​archpsyc.​63.​3.​283. This is a landmark study of pharmacologic intervention for depression following hospitalization for an acute coronary event. Prior episodes of depression and currently elevated level of severity predicted which patients would benefit for sertraline. Some have argued that patients hospitalized for an acute coronary event who have a prior history of major depression should receive prophylactic antidepressant treatment even is their level of symptoms do not reach criteria for a major depressive disorder.
17.
Zurück zum Zitat Xiong GL, Prybol K, Boyle SH, Hall R, Streilein RD, Steffens DC, et al. Inflammation markers and major depressive disorder in patients with chronic heart failure: results from the sertraline against depression and heart disease in chronic heart failure study. Psychosom Med. 2015;77(7):808–15.CrossRefPubMed Xiong GL, Prybol K, Boyle SH, Hall R, Streilein RD, Steffens DC, et al. Inflammation markers and major depressive disorder in patients with chronic heart failure: results from the sertraline against depression and heart disease in chronic heart failure study. Psychosom Med. 2015;77(7):808–15.CrossRefPubMed
18.
Zurück zum Zitat Sokoreli I, de Vries JJ, Pauws SC, Steyerberg EW. Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis. Heart Fail Rev. 2015. Sokoreli I, de Vries JJ, Pauws SC, Steyerberg EW. Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis. Heart Fail Rev. 2015.
19.•
Zurück zum Zitat Brouwers C, Christensen SB, Damen NL, Denollet J, Torp-Pedersen C, Gislason GH, et al. ntidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression. Int J Cardiol. 2015;203:867–73. This study and reference 20 are noteworthy for finding of no benefits form antidepressants among CHF patients. However the frequency with which antidepressants were prescribed without an accompanying documentation of a depressive disorder raises questions about the quality of the prescribing including indications, choice of medication, dose and duration of treatment. Brouwers C, Christensen SB, Damen NL, Denollet J, Torp-Pedersen C, Gislason GH, et al. ntidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression. Int J Cardiol. 2015;203:867–73. This study and reference 20 are noteworthy for finding of no benefits form antidepressants among CHF patients. However the frequency with which antidepressants were prescribed without an accompanying documentation of a depressive disorder raises questions about the quality of the prescribing including indications, choice of medication, dose and duration of treatment.
20.•
Zurück zum Zitat O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol. 2010;56(9):692–9. Carefully prescribed sertraline did not harm but did not benefit CHF patients with depression. O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol. 2010;56(9):692–9. Carefully prescribed sertraline did not harm but did not benefit CHF patients with depression.
21.
Zurück zum Zitat Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH. Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med. 2015;175(11):1773–82.CrossRefPubMed Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH. Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med. 2015;175(11):1773–82.CrossRefPubMed
22.
Zurück zum Zitat Tu RH, Zeng ZY, Zhong GQ, Wu WF, Lu YJ, Bo ZD, et al. Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail. 2014;16(7):749–57.CrossRefPubMed Tu RH, Zeng ZY, Zhong GQ, Wu WF, Lu YJ, Bo ZD, et al. Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail. 2014;16(7):749–57.CrossRefPubMed
23.
24.
Zurück zum Zitat Scazufca M, Menezes P, Tabb K, Kester R, Rössler W, Huang H. Identification and treatment of depression of older adults in primary care: findings from the São Paulo ageing and health study. Fam Pract. 2015. Scazufca M, Menezes P, Tabb K, Kester R, Rössler W, Huang H. Identification and treatment of depression of older adults in primary care: findings from the São Paulo ageing and health study. Fam Pract. 2015.
25.
Zurück zum Zitat Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377:1778–97.CrossRefPubMed Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377:1778–97.CrossRefPubMed
26.
Zurück zum Zitat Ford AH, Flicker L, Hankey GJ, Yeap BB, Chubb SA, Golledge J, et al. Insulin resistance and depressive symptoms in older men: the health in men study. Am J Geriatr Psychiatry. 2015;23(8):872–80.CrossRefPubMed Ford AH, Flicker L, Hankey GJ, Yeap BB, Chubb SA, Golledge J, et al. Insulin resistance and depressive symptoms in older men: the health in men study. Am J Geriatr Psychiatry. 2015;23(8):872–80.CrossRefPubMed
27.
Zurück zum Zitat Stoop CH, Nefs G, Pommer AM, Pop VJ, Pouwer F. Effectiveness of a stepped care intervention for anxiety and depression in people with diabetes, asthma or COPD in primary care: a randomized controlled trial. J Affect Disord. 2015;184:269–76. doi:10.1016/j.jad.2015.05.063.CrossRefPubMed Stoop CH, Nefs G, Pommer AM, Pop VJ, Pouwer F. Effectiveness of a stepped care intervention for anxiety and depression in people with diabetes, asthma or COPD in primary care: a randomized controlled trial. J Affect Disord. 2015;184:269–76. doi:10.​1016/​j.​jad.​2015.​05.​063.CrossRefPubMed
28.
Zurück zum Zitat Lin EH, Von Korff M, Peterson D, Ludman EJ, Ciechanowski P, Katon W. Population targeting and durability of multimorbidity collaborative care management. Am J Manag Care. 2014;20(11):887–95.PubMedPubMedCentral Lin EH, Von Korff M, Peterson D, Ludman EJ, Ciechanowski P, Katon W. Population targeting and durability of multimorbidity collaborative care management. Am J Manag Care. 2014;20(11):887–95.PubMedPubMedCentral
29.
Zurück zum Zitat Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–20.CrossRefPubMedPubMedCentral Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–20.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Porensky EK, Dew MA, Karp JF, et al. The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry. 2009;17:473–82.CrossRefPubMedPubMedCentral Porensky EK, Dew MA, Karp JF, et al. The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry. 2009;17:473–82.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Mantella RC, Butters MA, Dew MA, et al. Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry. 2007;15:673–9.CrossRefPubMed Mantella RC, Butters MA, Dew MA, et al. Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry. 2007;15:673–9.CrossRefPubMed
32.
Zurück zum Zitat Caudle DD, Senior AC, Wetherell JL, et al. Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry. 2007;15:680–9.CrossRefPubMed Caudle DD, Senior AC, Wetherell JL, et al. Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry. 2007;15:680–9.CrossRefPubMed
33.
Zurück zum Zitat Stanley MA, Beck JG, Novy DM, et al. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol. 2003;71:309–19.CrossRefPubMed Stanley MA, Beck JG, Novy DM, et al. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol. 2003;71:309–19.CrossRefPubMed
34.
Zurück zum Zitat Wetherell JL, Thorp SR, Patterson TL, et al. Quality of life in geriatric generalized anxiety disorder: a preliminary investigation. J Psychiatr Res. 2004;38:305–12.CrossRefPubMed Wetherell JL, Thorp SR, Patterson TL, et al. Quality of life in geriatric generalized anxiety disorder: a preliminary investigation. J Psychiatr Res. 2004;38:305–12.CrossRefPubMed
35.
Zurück zum Zitat Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry. 2009;70 Suppl 2:20–4.CrossRefPubMed Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry. 2009;70 Suppl 2:20–4.CrossRefPubMed
36.
Zurück zum Zitat Robinson RG, Jorge RE, Moser DJ, et al. Escitalopram and problem solving therapy for prevention of post-stroke depression: a randomized controlled trial. JAMA. 2008;299:2391–400.CrossRefPubMedPubMedCentral Robinson RG, Jorge RE, Moser DJ, et al. Escitalopram and problem solving therapy for prevention of post-stroke depression: a randomized controlled trial. JAMA. 2008;299:2391–400.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Hackett MI, Anderson CS, House A, et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008. CD003437. Hackett MI, Anderson CS, House A, et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008. CD003437.
38.
Zurück zum Zitat Wu CS, Wang SC, Cheng YC. Association of cerebrovascular events with antidepressant use: a cross-over study. Am J Psychiatry. 2011;168:511–21.CrossRefPubMed Wu CS, Wang SC, Cheng YC. Association of cerebrovascular events with antidepressant use: a cross-over study. Am J Psychiatry. 2011;168:511–21.CrossRefPubMed
39.•
Zurück zum Zitat Mikami K, Jorge RE, Moser DJ, Arndt S, Jang M, Solodkin A, et al. Prevention of post-stroke generalized anxiety disorder, using escitalopram or problem-solving therapy. J Neuropsychiatry Clin Neurosci. 2014;26(4):323–8. doi:10.1176/appi.neuropsych.11020047. This study is another example of how antidepressant therapy needs to be coupled with disease specific psychotherapy in the context of multi-morbidity to achieve the desired results. Mikami K, Jorge RE, Moser DJ, Arndt S, Jang M, Solodkin A, et al. Prevention of post-stroke generalized anxiety disorder, using escitalopram or problem-solving therapy. J Neuropsychiatry Clin Neurosci. 2014;26(4):323–8. doi:10.​1176/​appi.​neuropsych.​11020047. This study is another example of how antidepressant therapy needs to be coupled with disease specific psychotherapy in the context of multi-morbidity to achieve the desired results.
40.
Zurück zum Zitat Kua J. The prevalence of psychological and psychiatric sequellae of cancer in the elderly—how much do we know? Ann Acad Med. 2005;34(3):250–6. Kua J. The prevalence of psychological and psychiatric sequellae of cancer in the elderly—how much do we know? Ann Acad Med. 2005;34(3):250–6.
41.
Zurück zum Zitat Mandelblatt JS, Hurria A, McDonald BC, et al. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol. 2013;40(6):709–25.CrossRefPubMed Mandelblatt JS, Hurria A, McDonald BC, et al. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol. 2013;40(6):709–25.CrossRefPubMed
42.
Zurück zum Zitat Agarwal M, Hamilton JB, Moore CE, Crandell JL. Predictors of depression among older African American cancer patients. Cancer Nurs. 2010;33(2):156–63.PubMedPubMedCentral Agarwal M, Hamilton JB, Moore CE, Crandell JL. Predictors of depression among older African American cancer patients. Cancer Nurs. 2010;33(2):156–63.PubMedPubMedCentral
43.
Zurück zum Zitat Puts MT, Monette J, Girre V, Wolfson C, Monette M, Batist G, et al. Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study. Ann Oncol. 2011;22(4):916–23.CrossRefPubMedPubMedCentral Puts MT, Monette J, Girre V, Wolfson C, Monette M, Batist G, et al. Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study. Ann Oncol. 2011;22(4):916–23.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Saracino RM, Rosenfeld B, Nelson CJ. Towards a new conceptualization of depression in older adult cancer patients: a review of the literature. Aging Ment Health. 2015;27:1–13.CrossRef Saracino RM, Rosenfeld B, Nelson CJ. Towards a new conceptualization of depression in older adult cancer patients: a review of the literature. Aging Ment Health. 2015;27:1–13.CrossRef
45.
Zurück zum Zitat Heine C, Browning CJ. Mental health and dual sensory loss in older adults: a systematic review. Front Aging Neurosci. 2014;6(83):1–9. Heine C, Browning CJ. Mental health and dual sensory loss in older adults: a systematic review. Front Aging Neurosci. 2014;6(83):1–9.
46.
Zurück zum Zitat Kiely KM, Anstey KJ, Luszcz MA. Dual sensory loss and depressive symptoms: the importance of hearing, daily functioning, and activity engagement. Front Hum Neurosci. 2013;7(837):1–13. Kiely KM, Anstey KJ, Luszcz MA. Dual sensory loss and depressive symptoms: the importance of hearing, daily functioning, and activity engagement. Front Hum Neurosci. 2013;7(837):1–13.
47.
Zurück zum Zitat Court H, McLean G, Guthrie B, Mercer SW, Smith DJ. Visual impairment is associated with physical and mental comorbidities in older adults: a cross-sectional study. BMC Med. 2014;12(181):1–8. Court H, McLean G, Guthrie B, Mercer SW, Smith DJ. Visual impairment is associated with physical and mental comorbidities in older adults: a cross-sectional study. BMC Med. 2014;12(181):1–8.
48.
Zurück zum Zitat Meuleners LB, Hendrie D, Fraser ML, Ng JQ, Morlet N. The impact of first eye cataract surgery on mental health contacts for depression and/or anxiety: a population-based study using linked data. Acta Ophthalmol. 2013;91:e445–9.CrossRefPubMed Meuleners LB, Hendrie D, Fraser ML, Ng JQ, Morlet N. The impact of first eye cataract surgery on mental health contacts for depression and/or anxiety: a population-based study using linked data. Acta Ophthalmol. 2013;91:e445–9.CrossRefPubMed
49.
Zurück zum Zitat Gall C, Brösel D, Sabel BA. Remaining visual field and preserved subjective visual functioning prevent mental distress in patients with visual field defects. Front Hum Neurosci. 2013;7(584):1–8. Gall C, Brösel D, Sabel BA. Remaining visual field and preserved subjective visual functioning prevent mental distress in patients with visual field defects. Front Hum Neurosci. 2013;7(584):1–8.
50.•
Zurück zum Zitat Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, et al. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014;121(11):2204–11. In previous studies the authors were able to reduce the incidence of depression among persons visual impairment in one eye prior to the onset of impairment due to macular degeneration in the second eye. Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, et al. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014;121(11):2204–11. In previous studies the authors were able to reduce the incidence of depression among persons visual impairment in one eye prior to the onset of impairment due to macular degeneration in the second eye.
51.
Zurück zum Zitat Bautovich A, Katz I, Smith M, Harvey SB. Depression and chronic kidney disease: a review for clinicians. Aust N Z J Psychiatry. 2014;48(6):530–41.CrossRefPubMed Bautovich A, Katz I, Smith M, Harvey SB. Depression and chronic kidney disease: a review for clinicians. Aust N Z J Psychiatry. 2014;48(6):530–41.CrossRefPubMed
52.
Zurück zum Zitat Loosman WL, Rottier MA, Honig A, Siegert CE. Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study. BMC Nephrol. 2015;16(1):155.CrossRefPubMedPubMedCentral Loosman WL, Rottier MA, Honig A, Siegert CE. Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study. BMC Nephrol. 2015;16(1):155.CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Yu MK, Katon W, Young BA. Diabetes self-care, major depression, and chronic kidney disease in an outpatient diabetic population. Nephron Clin Pract. 2013;124:106–12.CrossRefPubMedPubMedCentral Yu MK, Katon W, Young BA. Diabetes self-care, major depression, and chronic kidney disease in an outpatient diabetic population. Nephron Clin Pract. 2013;124:106–12.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendation by the European Renal Best Practices (ERBP). Nephrol Dial Transplant. 2012;27:3736–45.CrossRefPubMed Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendation by the European Renal Best Practices (ERBP). Nephrol Dial Transplant. 2012;27:3736–45.CrossRefPubMed
55.
Zurück zum Zitat Joshi N, Khanna R, Shah RM. Relationship between depression and physical activity, disability, burden, and health-related quality of life among patients with arthritis. Popul Health Manag. 2015;18:104–14.CrossRefPubMed Joshi N, Khanna R, Shah RM. Relationship between depression and physical activity, disability, burden, and health-related quality of life among patients with arthritis. Popul Health Manag. 2015;18:104–14.CrossRefPubMed
56.
Zurück zum Zitat Gandhi R, Syweil MG, Mahomed NN, Perruccio AV. Depression and the overall burden of painful joints: an examination among oindiiviiduals undergoing hip and knee replacement for osteoarthritis. Arthritis 2015;327 Gandhi R, Syweil MG, Mahomed NN, Perruccio AV. Depression and the overall burden of painful joints: an examination among oindiiviiduals undergoing hip and knee replacement for osteoarthritis. Arthritis 2015;327
57.
Zurück zum Zitat Agarwal P, Sambamoorthi U. Healthcare expenditures associated with depression among individuals with osteoarthritis: post-regression linear decomposition approach. J Gen Intern Med. 2015;30:1803–11.CrossRefPubMed Agarwal P, Sambamoorthi U. Healthcare expenditures associated with depression among individuals with osteoarthritis: post-regression linear decomposition approach. J Gen Intern Med. 2015;30:1803–11.CrossRefPubMed
58.
Zurück zum Zitat Tan V, Jinks C, Chew-Graham C, et al. The triple whammy anxiety depression and osteoarthritis in long-term condition. BMC Fam Pract. 2015;16:163.CrossRefPubMedPubMedCentral Tan V, Jinks C, Chew-Graham C, et al. The triple whammy anxiety depression and osteoarthritis in long-term condition. BMC Fam Pract. 2015;16:163.CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Lin MC, Guo HR, Lu MC, et al. Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study. Clinics (Sao Paulo). 2015;70:91–6.CrossRef Lin MC, Guo HR, Lu MC, et al. Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study. Clinics (Sao Paulo). 2015;70:91–6.CrossRef
60.
Zurück zum Zitat Matcham F, Norton S, Scott DL, et al. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized trial. Rheumatology (Oxford) 2015. Matcham F, Norton S, Scott DL, et al. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized trial. Rheumatology (Oxford) 2015.
61.
Zurück zum Zitat Parker JC, Smarr KL, Slaughter JR, et al. Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum. 2003;49:766–77.CrossRefPubMed Parker JC, Smarr KL, Slaughter JR, et al. Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum. 2003;49:766–77.CrossRefPubMed
62.
Zurück zum Zitat Bird H, Brogini M. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. J Rheumatol. 2000;27:2791–7.PubMed Bird H, Brogini M. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. J Rheumatol. 2000;27:2791–7.PubMed
63.
Zurück zum Zitat Kelly GA, Kelley KS, Hootman JM. Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials. Arthritis Res Ther. 2015;17:21.CrossRef Kelly GA, Kelley KS, Hootman JM. Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials. Arthritis Res Ther. 2015;17:21.CrossRef
64.
Zurück zum Zitat Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(02):126–33.CrossRefPubMedPubMedCentral Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(02):126–33.CrossRefPubMedPubMedCentral
65.••
Zurück zum Zitat Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache county study. Int J Geriat Psychiatry. 2008;23(2):170–7. The importance of this study is based on the highly representative character of the community-based sample as well as the analysis showing three clusters of neuropsychiatric symptoms. Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache county study. Int J Geriat Psychiatry. 2008;23(2):170–7. The importance of this study is based on the highly representative character of the community-based sample as well as the analysis showing three clusters of neuropsychiatric symptoms.
66.
Zurück zum Zitat Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79(2):184–90.CrossRefPubMed Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79(2):184–90.CrossRefPubMed
67.
Zurück zum Zitat Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, et al. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache county dementia progression study. Am J Psychiatr AJP. 2015;172(5):460–5.CrossRef Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, et al. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache county dementia progression study. Am J Psychiatr AJP. 2015;172(5):460–5.CrossRef
68.
Zurück zum Zitat Apostolova LG, Di LJ, Duffy EL, Brook J, Elashoff D, Tseng CH, et al. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer’s disease. Dement Geriatr Cogn Disord. 2014;37:315–26.CrossRefPubMedPubMedCentral Apostolova LG, Di LJ, Duffy EL, Brook J, Elashoff D, Tseng CH, et al. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer’s disease. Dement Geriatr Cogn Disord. 2014;37:315–26.CrossRefPubMedPubMedCentral
69.
70.
Zurück zum Zitat Spalletta G, Musicco M, Padovani A, Rozzini L, Perri R, Fadda L, et al. Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry. 2010;18(11):1026–35.CrossRefPubMed Spalletta G, Musicco M, Padovani A, Rozzini L, Perri R, Fadda L, et al. Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry. 2010;18(11):1026–35.CrossRefPubMed
71.
Zurück zum Zitat Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 2012;69(5):493–8 Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 2012;69(5):493–8
72.
Zurück zum Zitat Wilson RS, Boyle PA, Capuano AW, Shah RC, Hoganson GM, Nag S, et al. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2015. doi:10.1037/neu0000223. Wilson RS, Boyle PA, Capuano AW, Shah RC, Hoganson GM, Nag S, et al. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2015. doi:10.​1037/​neu0000223.
73.•
Zurück zum Zitat Hodgson NA, Gitlin LN, Winter L, Czekanski K. Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia. Alzheimer Dis Assoc Disord. 2011;25(2):109–15. This study is yet again a reminder that sudden change in mental status calls for a search for reversible cause most notably infection. Hodgson NA, Gitlin LN, Winter L, Czekanski K. Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia. Alzheimer Dis Assoc Disord. 2011;25(2):109–15. This study is yet again a reminder that sudden change in mental status calls for a search for reversible cause most notably infection.
74.•
Zurück zum Zitat Brodaty H, Arasaratnam C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatr AJP. 2012;169(9):946–53. Noteworthy review of risk and benefits of pharmacotherapy for neuropsychiatric symptoms of dementia. Brodaty H, Arasaratnam C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatr AJP. 2012;169(9):946–53. Noteworthy review of risk and benefits of pharmacotherapy for neuropsychiatric symptoms of dementia.
75.
Zurück zum Zitat Seitz DP, Brisbin S, Herrmann N, Rapoport MJ, Wilson K, Gill SS, et al. Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review. J Am Med Dir Assoc. 2012:13 Suppl 6. Seitz DP, Brisbin S, Herrmann N, Rapoport MJ, Wilson K, Gill SS, et al. Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review. J Am Med Dir Assoc. 2012:13 Suppl 6.
76.
Zurück zum Zitat Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N, et al. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technol Assess. 2014;18(39):1–226. doi:10.3310/hta18390. v-vi.CrossRef Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N, et al. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technol Assess. 2014;18(39):1–226. doi:10.​3310/​hta18390. v-vi.CrossRef
77.
Zurück zum Zitat Nelson L, Tabet N. Slowing the progression of Alzheimer’s disease; what works? Ageing Res Rev. 2015;23:193–209.CrossRefPubMed Nelson L, Tabet N. Slowing the progression of Alzheimer’s disease; what works? Ageing Res Rev. 2015;23:193–209.CrossRefPubMed
78.
Zurück zum Zitat Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403–11.CrossRefPubMed Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403–11.CrossRefPubMed
79.
Zurück zum Zitat Ballard CG. Atypical antipsychotics for aggression and psychosis in Alzheimer’s disease. Cochrane Database Syst Rev. 2012. Ballard CG. Atypical antipsychotics for aggression and psychosis in Alzheimer’s disease. Cochrane Database Syst Rev. 2012.
80.
Zurück zum Zitat Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med. 2006;355(15):1525–38.CrossRefPubMed Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med. 2006;355(15):1525–38.CrossRefPubMed
81.•
Zurück zum Zitat Porsteinsson AP Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, et al. Effect of citalopram on agitation in Alzheimer disease. JAMA. 2014;311(7):682. Important findings reinforce the dictum of when in doubt about what to prescribe an agitation choose an antidepressant. However the doses of citalopram employed in the study would be considered excessive under current guidelines. Porsteinsson AP Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, et al. Effect of citalopram on agitation in Alzheimer disease. JAMA. 2014;311(7):682. Important findings reinforce the dictum of when in doubt about what to prescribe an agitation choose an antidepressant. However the doses of citalopram employed in the study would be considered excessive under current guidelines.
82.
Zurück zum Zitat Pollock BG, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR, et al. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry. 2007;15(11):942–52.CrossRefPubMed Pollock BG, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR, et al. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry. 2007;15(11):942–52.CrossRefPubMed
83.•
Zurück zum Zitat Cummings JL, Lyketsos CG, Peskind ER, et al. Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer disease dementia: a randomized clinical trial. JAMA. 2015;314(12):1242–54. doi:10.1001/jama.2015.10214. Novel study design with intriguing findings that await replication. Cummings JL, Lyketsos CG, Peskind ER, et al. Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer disease dementia: a randomized clinical trial. JAMA. 2015;314(12):1242–54. doi:10.​1001/​jama.​2015.​10214. Novel study design with intriguing findings that await replication.
84.
Zurück zum Zitat Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343:D4065.CrossRefPubMedPubMedCentral Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343:D4065.CrossRefPubMedPubMedCentral
85.
Zurück zum Zitat Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, et al. Safety and efficacy of methylphenidate for apathy in Alzheimer’s disease. J Clin Psychiatry. 2013;74(08):810–6.CrossRefPubMedPubMedCentral Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, et al. Safety and efficacy of methylphenidate for apathy in Alzheimer’s disease. J Clin Psychiatry. 2013;74(08):810–6.CrossRefPubMedPubMedCentral
86.
Zurück zum Zitat Padala PR, Burke WJ, Shostrom VK, Bhatia SC, Wengel SP, Potter JF, et al. Methylphenidate for apathy and functional status in dementia of the Alzheimer type. Am J Geriatr Psychiatry. 2010;18(4):371–4.CrossRefPubMed Padala PR, Burke WJ, Shostrom VK, Bhatia SC, Wengel SP, Potter JF, et al. Methylphenidate for apathy and functional status in dementia of the Alzheimer type. Am J Geriatr Psychiatry. 2010;18(4):371–4.CrossRefPubMed
87.•
Zurück zum Zitat Blow FC, Barry K. Alcohol and substance misuse in older adults. Curr Psychiatry Rep. 2012;14(4):310–9. Highly pragmatic review of basic and more advanced interventions. Blow FC, Barry K. Alcohol and substance misuse in older adults. Curr Psychiatry Rep. 2012;14(4):310–9. Highly pragmatic review of basic and more advanced interventions.
88.
Zurück zum Zitat Rigler SK. Alcoholism in the elderly. Am Fam Physician. 2000;61 Suppl 6:1710–6, 1883–4, 1887–8 passim. Rigler SK. Alcoholism in the elderly. Am Fam Physician. 2000;61 Suppl 6:1710–6, 1883–4, 1887–8 passim.
90.
Zurück zum Zitat Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath Jr CW, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337(24):1705–14.CrossRefPubMed Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath Jr CW, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337(24):1705–14.CrossRefPubMed
Metadaten
Titel
Psychiatric and Medical Comorbidity in the Primary Care Geriatric Patient—An Update
Publikationsdatum
01.07.2016
Erschienen in
Current Psychiatry Reports / Ausgabe 7/2016
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-016-0700-7

Weitere Artikel der Ausgabe 7/2016

Current Psychiatry Reports 7/2016 Zur Ausgabe

Substance Use and Related Disorders (F Levin and E Dakwar, Section Editors)

New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders

Sleep Disorders (P Gehrman, Section Editor)

Disturbed Sleep and Postpartum Depression

Eating Disorders (C Grilo, Section Editor)

Hormonal Factors and Disturbances in Eating Disorders

Sexual Disorders (G Dwyer, Section Editor)

Juvenile Sex Offenders

Schizophrenia and Other Psychotic Disorders (SJ Siegel, Section Editor)

Systematic Review of Clozapine Cardiotoxicity

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.